T
Takashi Koyano
Researcher at Chiba University
Publications - 94
Citations - 1904
Takashi Koyano is an academic researcher from Chiba University. The author has contributed to research in topics: Cell culture & Wnt signaling pathway. The author has an hindex of 25, co-authored 94 publications receiving 1759 citations. Previous affiliations of Takashi Koyano include Kyoto Prefectural University of Medicine & Keio University.
Papers
More filters
Journal ArticleDOI
Naturally occurring small-molecule inhibitors of hedgehog/GLI-mediated transcription.
TL;DR: The results strongly suggest that the cytotoxicity of the compounds to PANC1 cells correlates with their inhibition of GLI‐mediated transcription, and that these compounds were cytotoxic to P ANC1 pancreatic cancer cells, which express Hh/GLI components.
Journal ArticleDOI
Induction of normal phenotypes in ras-transformed cells by damnacanthal from Morinda citrifolia
TL;DR: The compound isolated from the chloroform extract of the root of Morinda citrifolia induced normal morphology and cytoskeletal structure in K-rasts-NRK cells at the permissive temperature, without changing the amount and localization of Ras.
Journal ArticleDOI
Cyclopentabenzofuran lignan protein synthesis inhibitors from Aglaia odorata.
TL;DR: Aglaiastatin reduced the amount of Ras, possibly by inhibiting its de novo synthesis, and was slightly more potent than 1 and 2 in inhibiting cell growth.
Journal ArticleDOI
Leishmanicidal alkaloids from Kopsia griffithii
TL;DR: Thirteen alkaloids were isolated from the stem-bark extract of Kopsia griffithii, of which three were new, and Harmane, pleiocarpine and buchtienine showed antileishmanial activity.
Journal ArticleDOI
Dihydroflavonol BB-1, an extract of natural plant Blumea balsamifera, abrogates TRAIL resistance in leukemia cells.
Hiroo Hasegawa,Yasuaki Yamada,Kanki Komiyama,Masahiko Hayashi,Masami Ishibashi,Tatsushi Yoshida,Toshiyuki Sakai,Takashi Koyano,Toh-Seok Kam,Ken Murata,Kazuyuki Sugahara,Kazuto Tsuruda,Norihiko Akamatsu,Kunihiro Tsukasaki,Masato Masuda,Nobuyuki Takasu,Shimeru Kamihira +16 more
TL;DR: A dihydroflavonol that was extracted from Blumea balsamifera (BB-1) exhibited the most striking synergism with TRAIL, suggesting that combined treatment with BB-1 and TRAIL may be a new strategy for cancer therapy.